Home | NGcGM3/VSSP and nimotuzumab in patients with triple negative breast cancer
Published clinical_trials NGcGM3/VSSP and nimotuzumab in patients with triple negative breast cancer has 11 revisions.
RevisionStatus
Saved 22/12/2016 - 11:39am by CIM
current revision (published)
Saved 22/12/2016 - 11:37am by CIM
archived
Saved 22/12/2016 - 11:37am by CIM
archived
Saved 22/12/2016 - 11:37am by CIM
archived
Saved 22/12/2016 - 11:37am by CIM
archived
Saved 22/12/2016 - 11:37am by CIM
archived
Saved 22/12/2016 - 11:37am by CIM
archived
Saved 22/12/2016 - 11:36am by CIM
archived
Saved 22/12/2016 - 11:36am by CIM
archived
Saved 22/12/2016 - 11:36am by CIM
archived
Saved 12/10/2016 - 5:08pm by Gladys
archived
Equipo de Trabajo del RPCEC | CENCEC - MINSAP
rpcec@cencec.sld.cu
Calle 5ta A Edificio CECMED-CENCEC 2do piso e/ 60 y 62 Miramar, Playa.CP 11300. La Habana, Cuba
Telef: (537) 216-4126 | (537) 216-4212 | (537) 216-4218.
Copyright © 2014-2022 All Rights Reserved.